NCORP Tissue Procurement Protocol: An NCI Cancer Moonshot Study
A031702 (Miscellaneous GU Tract Histologic Variants cohort temp suspended 9/23/19) (Small cell ca of bladder cohort temp suspended 12/19/19)
Phase II Study of Cabozantinib in Combination with Nivolumab and Ipilimumab in Rare Genitourinary Tumors
DART: Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors
MATCH: Molecular analysis for therapy choice. Targeted therapy directed by genetic testing in treating patients with advanced refractory solid tumors or lymphoma.